{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:05:28Z","timestamp":1789686328056,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13907-1","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:34:14Z","timestamp":1782815654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic changes in vasoactive-inotropic score and their prognostic value in severe sepsis and septic shock patients undergoing polymyxin B hemoperfusion: a real-world Asian ICU cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Wei-Hung","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Fang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"13907_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"key":"13907_CR2","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1001\/jama.2020.2717","volume":"323","author":"JL Vincent","year":"2020","unstructured":"Vincent JL, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017 (EPIC III). JAMA. 2020;323:1478\u201387. https:\/\/doi.org\/10.1001\/jama.2020.2717.","journal-title":"JAMA"},{"key":"13907_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority - a WHO resolution. N Engl J Med. 2017;377:414\u20137. https:\/\/doi.org\/10.1056\/NEJMp1707170.","journal-title":"N Engl J Med"},{"key":"13907_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y.","journal-title":"Intensive Care Med"},{"key":"13907_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304\u201377. https:\/\/doi.org\/10.1007\/s00134-017-4683-6.","journal-title":"Intensive Care Med"},{"key":"13907_CR6","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376:2235\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1703058.","journal-title":"N Engl J Med"},{"key":"13907_CR7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jama.2017.13836","volume":"318","author":"C Rhee","year":"2017","unstructured":"Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009\u20132014. JAMA. 2017;318:1241\u20139. https:\/\/doi.org\/10.1001\/jama.2017.13836.","journal-title":"JAMA"},{"key":"13907_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"13907_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:775\u201387. https:\/\/doi.org\/10.1001\/jama.2016.0289.","journal-title":"JAMA"},{"key":"13907_CR10","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:762\u201374. https:\/\/doi.org\/10.1001\/jama.2016.0288.","journal-title":"JAMA"},{"key":"13907_CR11","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045. https:\/\/doi.org\/10.1038\/nrdp.2016.45.","journal-title":"Nat Rev Dis Primers"},{"key":"13907_CR12","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54:2450\u201364. https:\/\/doi.org\/10.1016\/j.immuni.2021.10.012.","journal-title":"Immunity"},{"key":"13907_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818\u201329. https:\/\/doi.org\/10.1097\/00003246-198510000-00009.","journal-title":"Crit Care Med"},{"key":"13907_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/jcm10030495","volume":"10","author":"J Song","year":"2021","unstructured":"Song J, Cho H, Park DW, Moon S, Kim JY, Ahn S, et al. Vasoactive-inotropic score as an early predictor of mortality in adult patients with sepsis. J Clin Med. 2021;10:495. https:\/\/doi.org\/10.3390\/jcm10030495.","journal-title":"J Clin Med"},{"key":"13907_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13054-023-04690-5","volume":"27","author":"JA Kellum","year":"2023","unstructured":"Kellum JA, Ronco C. The role of endotoxin in septic shock. Crit Care. 2023;27:400. https:\/\/doi.org\/10.1186\/s13054-023-04690-5.","journal-title":"Crit Care"},{"key":"13907_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s44158-022-00056-5","volume":"2","author":"H Shoji","year":"2022","unstructured":"Shoji H, Ferrer R. Potential survival benefit and early recovery from organ dysfunction with polymyxin B hemoperfusion: perspectives from a real-world big data analysis and supporting mechanisms of action. J Anesth Analg Crit Care. 2022;2:27. https:\/\/doi.org\/10.1186\/s44158-022-00056-5.","journal-title":"J Anesth Analg Crit Care"},{"key":"13907_CR17","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, et al. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin activity: the EUPHRATES randomized clinical trial. JAMA. 2018;320:1455\u201363. https:\/\/doi.org\/10.1001\/jama.2018.14618.","journal-title":"JAMA"},{"key":"13907_CR18","doi-asserted-by":"publisher","first-page":"e33735","DOI":"10.1016\/j.heliyon.2024.e33735","volume":"10","author":"C Li","year":"2024","unstructured":"Li C, Zhang J, Yang P, Wang R, Chen T, Li L. The role of polymyxin B-immobilized hemoperfusion in reducing mortality and enhancing hemodynamics in patients with sepsis and septic shock: a systematic review and meta-analysis. Heliyon. 2024;10:e33735. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33735.","journal-title":"Heliyon"},{"key":"13907_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/sur.2016.168","volume":"18","author":"T Terayama","year":"2017","unstructured":"Terayama T, Yamakawa K, Umemura Y, Aihara M, Fujimi S. Polymyxin B hemoperfusion for sepsis and septic shock: a systematic review and meta-analysis. Surg Infect (Larchmt). 2017;18:225\u201333. https:\/\/doi.org\/10.1089\/sur.2016.168.","journal-title":"Surg Infect (Larchmt)"},{"key":"13907_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jinf.2017.08.012","volume":"75","author":"CC Lee","year":"2017","unstructured":"Lee CC, Yo CH, Lee MTG, Tsai KC, Lee SH, Chen YS, et al. Adult sepsis: nationwide trends and outcomes in a population of 23 million people. J Infect. 2017;75:409\u201319. https:\/\/doi.org\/10.1016\/j.jinf.2017.08.012.","journal-title":"J Infect"},{"key":"13907_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/SHK.0000000000001219","volume":"51","author":"CW Yu","year":"2019","unstructured":"Yu CW, Chang SS, Lai CC, Wu JY, Yen DW, Lee MTG, et al. Epidemiology of emergency department sepsis: a national cohort study between 2001 and 2012. Shock. 2019;51:619\u201324. https:\/\/doi.org\/10.1097\/SHK.0000000000001219.","journal-title":"Shock"},{"key":"13907_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3390\/life15081317","volume":"15","author":"WH Chang","year":"2025","unstructured":"Chang WH, Hu TY, Kuo LK. Real-world outcomes and prognostic factors of polymyxin B hemoperfusion in severe sepsis and septic shock: a seven-year single-center cohort study from Taiwan. Life (Basel). 2025;15:1317. https:\/\/doi.org\/10.3390\/life15081317.","journal-title":"Life (Basel)"},{"key":"13907_CR23","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3390\/biomedicines13122904","volume":"13","author":"WH Chang","year":"2025","unstructured":"Chang WH, Yang SH, Shen HF, Hu TY, Wu WJ. Impact of continuous renal replacement therapy on outcomes in septic shock patients receiving polymyxin B hemoperfusion: a retrospective cohort study. Biomedicines. 2025;13:2904. https:\/\/doi.org\/10.3390\/biomedicines13122904.","journal-title":"Biomedicines"},{"key":"13907_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419\u201330. https:\/\/doi.org\/10.1056\/NEJMoa1704154.","journal-title":"N Engl J Med"},{"key":"13907_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1705716.","journal-title":"N Engl J Med"},{"key":"13907_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez G, Ospina-Tasc\u00f3n GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321:654\u201364. https:\/\/doi.org\/10.1001\/jama.2019.0071.","journal-title":"JAMA"},{"key":"13907_CR27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jama.2020.0930","volume":"323","author":"F Lamontagne","year":"2020","unstructured":"Lamontagne F, Richards-Belle A, Thomas K, Harrison DA, Sadique MZ, Grieve RD, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension (65 trial). JAMA. 2020;323:938\u201349. https:\/\/doi.org\/10.1001\/jama.2020.0930.","journal-title":"JAMA"},{"key":"13907_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2017.17687","volume":"319","author":"HC Prescott","year":"2018","unstructured":"Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. JAMA. 2018;319:62\u201375. https:\/\/doi.org\/10.1001\/jama.2017.17687.","journal-title":"JAMA"},{"key":"13907_CR29","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang CCH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321:2003\u201317. https:\/\/doi.org\/10.1001\/jama.2019.5791.","journal-title":"JAMA"},{"key":"13907_CR30","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","volume":"378","author":"MW Semler","year":"2018","unstructured":"Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378:829\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1711584.","journal-title":"N Engl J Med"},{"key":"13907_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/0885066618773679","volume":"35","author":"T Iba","year":"2020","unstructured":"Iba T, Arakawa M, Di Nisio M, Gando S, Anan H, Sato K, et al. Newly proposed sepsis-induced coagulopathy precedes International Society on Thrombosis and Haemostasis overt disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med. 2020;35:643\u20139. https:\/\/doi.org\/10.1177\/0885066618773679.","journal-title":"J Intensive Care Med"},{"key":"13907_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13054-023-04555-x","volume":"27","author":"G Wang","year":"2023","unstructured":"Wang G, He Y, Guo Q, Zhao Y, He J, Chen Y, et al. Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with lower 28-day mortality in sepsis: a systematic review and meta-analysis. Crit Care. 2023;27:275. https:\/\/doi.org\/10.1186\/s13054-023-04555-x.","journal-title":"Crit Care"},{"key":"13907_CR33","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.11825","volume":"322","author":"AA Fowler 3rd","year":"2019","unstructured":"Fowler AA 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure. JAMA. 2019;322:1261\u201370. https:\/\/doi.org\/10.1001\/jama.2019.11825.","journal-title":"JAMA"},{"key":"13907_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2019.22176","volume":"323","author":"T Fujii","year":"2020","unstructured":"Fujii T, Luethi N, Young PJ, Frei DR, Eastwood GM, French CJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA. 2020;323:423\u201331. https:\/\/doi.org\/10.1001\/jama.2019.22176.","journal-title":"JAMA"},{"key":"13907_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/jama.2020.24505","volume":"325","author":"JE Sevransky","year":"2021","unstructured":"Sevransky JE, Rothman RE, Hager DN, Bernard GR, Brown SM, Buchman TG, et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA. 2021;325:742\u201350. https:\/\/doi.org\/10.1001\/jama.2020.24505.","journal-title":"JAMA"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13907-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13907-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13907-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:40:02Z","timestamp":1789684802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13907-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13907"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13907-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of MacKay Memorial Hospital, Taipei, Taiwan (IRB No. 18MMHIS198e; approval date: 4 March 2019; approved study period: 4 March 2019 to 3 March 2020). The requirement for informed consent was waived due to the retrospective design and the use of de-identified clinical data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1677"}}